Abstract
Objective: To further investigate mechanisms of airway hyperreactivity among subjects with chronic cervical spinal cord injury (SCI), we assessed airway responsiveness to aerosolized methacholine and histamine in subjects receiving chronic oxybutynin chloride therapy, and compared the findings with those not receiving the agent. Methods: Twenty-five male subjects with cervical SCI participated in this study; 12 were maintained on oral oxybutynin chloride and 13 served as age-matched controls. Six of the 12 subjects receiving oxybutynin were challenged with aerosolized methacholine, and six with histamine; seven of the 13 control subjects were challenged with aerosolized methacholine and the remaining six with histamine. Results: All 13 control subjects and all six oxybutynin/histamine subjects exhibited a significant bronchoconstrictor response (PC20<8 mg/ml), whereas mean PC20 values for the oxybutynin/methacholine group were ⩾25 mg/ml. Conclusion: Our finding that the bronchoconstrictor effects of methacholine were blocked by oxybutynin chloride while those of histamine were not suggests that oxybutynin acts primarily through anticholinergic pathways rather than by causing generalized airway smooth muscle relaxation.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singas, E., Grimm, D., Almenoff, P. et al. Inhibition of airway hyperreactivity by oxybutynin chloride in subjects with cervical spinal cord injury. Spinal Cord 37, 279–283 (1999). https://doi.org/10.1038/sj.sc.3100812
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.sc.3100812
Keywords
This article is cited by
-
A Center’s Experience: Pulmonary Function in Spinal Cord Injury
Lung (2014)
-
Cholinergic bronchomotor tone and airway caliber in tetraplegic patients
Spinal Cord (2006)
-
Characteristics of sleep apnea syndrome in tetraplegic patients
Spinal Cord (2002)